Elsevier Announces New Access to Reaxys(R) To Raise Performance And Output For Chemists at Sapienza University of Rome

By Elsevier Properties And Elsevier, PRNE
Monday, June 28, 2010

FRANKFURT, June 29, 2010 - Elsevier and Sapienza University of Rome today announced a new
agreement, providing researchers at the university with access to Reaxys
(www.info.reaxys.com/), Elsevier's workflow solution for research
chemists. Reflecting the way chemists think and work, Reaxys will enable
researchers at Sapienza to quickly find the chemistry relevant for their
needs and thereby raise their performance and output.

Marina Dalla Torre, Director of the Sapienza Chemistry
Library, said of the purchase, "From the first time we interacted with the
product, it was clear that it was a completely different one - user friendly
and liked by our students. The new access model also made possible to share
this resource with the Department of Pharmacology, and we are sure that other
departments will be interested as well."

Prof. Aldo Lagana, Sapienza's Head of Chemistry, added, "My
role is to support the sharing of chemistry knowledge and to provide
researchers with the best way to improve their performances, particularly
during this difficult economic period. Many colleagues have expressed their
strong interest in Reaxys, and I believe that their work, and the department
as a whole, will benefit from using it."

Offering experimentally validated information, Reaxys combines
reaction and substance data in organic, organometallic, inorganic and
physical chemistry with synthesis planning. Researchers can get the
information they need in a single overview, from source publications
carefully selected for their importance and relevance to research chemists.

"We have invested considerable time and effort to ensure that
Reaxys mirrors a chemist's research workflow" said Mark van Mierle, Managing
Director for Elsevier Information Systems. "This, combined with a simple
campus-wide access mechanism, will enable researchers to quickly identify the
most important and relevant information."

About Sapienza University of Rome

La Sapienza University of Rome, is the first university in
Rome and the largest in Europe. Founded in 1303, Sapienza has over 4500
professors and offers over 300 degree programmes. Sapienza plans and carries
out important scientific investigations in almost all disciplines and has 23
faculties, 112 departments and 30 centres devoted to scientific research.
High-standard results are achieved on both on a national and international
level.

About Elsevier Properties SA

Elsevier Properties SA is a center of excellence within Reed
Elsevier
for the management of intellectual property. Elsevier Properties SA
owns the PharmaPendium, Beilstein and Reaxys databases. Trademarks including
Reaxys(R), PharmaPendium(TM) and The Lancet(R) are owned and protected by
Elsevier Properties SA and used under license. For additional information see
www.reedelsevier.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical
and medical information products and services. The company works in
partnership with the global science and health communities to publish more
than 2,000 journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com),
Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and
Nursing Consult (www.nursingconsult.com), which enhance the
productivity of science and health professionals, and the SciVal suite
(www.scival.com) and MEDai's Pinpoint Review (www.medai.com),
which help research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier
(www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Tom Reller

    Vice President, Global Corporate Relations
    +1-215-239-3508
    T.Reller@Elsevier.com

Tom Reller, Vice President, Global Corporate Relations, +1-215-239-3508, T.Reller at Elsevier.com

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :